Datopotamab deruxtecan ... durable efficacy in patients with heavily pretreated
Wonder if this would work after T-DxD.
https://www.astrazeneca.com/media-ce...st-cancer.html Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive, HER2-low or negative metastatic breast cancer |
All times are GMT -7. The time now is 09:45 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021